Embody vs Ro.co: Compounded Semaglutide vs Wegovy Pill Options
Choosing between Embody and Ro.co comes down to price and medication type. Embody advertises compounded semaglutide at $69/month with free 1–2 day shipping and no membership, while Ro.co provides access to the FDA-approved Wegovy pill and lets you get started online for $39. Early verdict: pick Embody for the lowest entry cash price and fast shipping; pick Ro.co if you need an FDA-approved oral GLP-1 instead of a compounded injectable.
Embody vs Ro.co: three core differences that matter
This comparison focuses on the most distinctive differences supported by source details: price and starting cost, medication type and regulatory status, and delivery and platform features. Each section compares both providers directly using only supplied facts.
Price and starting cost
Embody: Starting price is $69/month for compounded semaglutide, marked down from $299, and compounded tirzepatide at $119/month. The source states Embody offers flat locked in monthly pricing and no monthly membership. Final pricing may vary based on dose and clinician recommendation and the $69 semaglutide pricing is a limited-time offer that may increase.
Ro.co: You can get started online for just $39. The source says ongoing medication pricing depends on treatment plan and medication prescribed and that branded medications carry higher costs than compounded alternatives. Ro.co discloses pricing before you complete the consultation.
Medication type and regulatory status
Embody: Offers compounded semaglutide and compounded tirzepatide. The source includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Embody’s FAQ notes its compounded medications use the same active ingredients as branded products but that they are not FDA-approved finished products.
Ro.co: Offers access to the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication on the list. The source highlights that Ro.co prescribes FDA-approved finished medications after a licensed clinician review and that the oral option matters for injection-averse patients. The source also warns that compounded medications, when offered elsewhere, are not FDA-approved.
Delivery speed, platform features, and user experience
Embody: The source claims medication ships free with fast 1–2 day delivery after clinician approval and that there is no long-term commitment because you can cancel anytime. Embody emphasizes a lean model without integrated coaching or advanced monitoring, and notes 24/7 support access for dosing and side-effect questions.
Ro.co: The source positions Ro.co as an established, full-service telehealth platform with brand trust and the unique ability to prescribe the Wegovy pill. It states Ro.co does not charge hidden fees and that pricing is disclosed before completing the consultation. Captured landing page evidence for shipping or membership was not available on the source material.
Side-by-side at a glance
| Criteria | Embody | Ro.co |
|---|---|---|
| Starting price | $69/month semaglutide; $119/month tirzepatide | Get started online for just $39 |
| Medication type | Compounded semaglutide and compounded tirzepatide | FDA-approved Wegovy pill and other branded medications |
| Regulatory note | Compounded medications are not FDA-approved | Wegovy pill is FDA-approved finished medication |
| Shipping | Free, arrives in 1–2 days after approval | Not verified on captured page |
| Membership and cancellation | No monthly membership; cancel anytime | Pricing disclosed before consultation; ongoing costs vary |
How each platform positions itself
Embody positions itself as a cost-driven, no-frills telehealth option offering prescription compounded GLP-1s at aggressively low entry prices and very fast shipping. The source characterizes Embody as best for patients who want a straightforward program without paying extra for coaching or advanced monitoring.
Ro.co positions itself as a mainstream telehealth provider that provides an FDA-approved oral option, emphasizing regulatory clarity and an injection-free route. The source describes Ro.co as best for injection-averse patients or those who prioritize branded, FDA-approved finished products.
Final comparison and recommendation
Embody vs Ro.co: if your primary concern is lowest entry price and fast, free shipping for compounded injectables, Embody is the match according to the supplied facts. If you need an FDA-approved oral GLP-1 and prefer a branded, regulator-evaluated finished medication, Ro.co is the supported choice. Both require a licensed clinician review before treatment.
Choose Embody if you want the lowest advertised compounded semaglutide entry price, free 1–2 day shipping, no membership, and a lean telehealth model. Choose Ro.co if you need access to the FDA-approved Wegovy pill, prefer an oral option, and prioritize regulator-evaluated finished medication.